Serum C-reactive protein and self-reported stroke: Findings from the Third National Health and Nutrition Examination Survey

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 4, 2000, Pages 1052-1056

  Ford, Earl S ^a   Giles, Wayne H ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

C reactive protein; Cerebrovascular diseases; Cross sectional studies; Health surveys; Risk factors

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; ENDOTHELIUM CELL; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN CONFORMATION; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0034114249     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.4.1052     Document Type: Article

References (26)

1. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine. New York, NY: Oxford University Press; 1996.
2. Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 1994;331:468-469.
3. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
4. Kushner I, Broder ML, Karp D. Control of the acute phase response: serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest. 1978;61:235-242.
5. de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J. 1982;47:239-243.
6. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
7. de Maat MPM, de Bart ACW. Hennis BC, Meijer P, Havelaar AC, Mulder PGH, Kluft C. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol. 1996;16:1156-1162.
8. Mori T, Sasaki J, Kawaguchi H, Handa K, Takada Y, Matsunaga A, Kono S, Arakawa K. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J. 1995;129:234-238.
9. Grau AJ, Buggle F, Becher H, Werle E, Hacke W. The association of leukocyte count, fibrinogen, and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res. 1996;82:245-255.
10. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312:1061-1065.
11. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in 'active' coronary artery disease. Am J Cardiol. 1990;65:168-172.
12. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
13. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Memostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332: 635-641.
14. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
15. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancer. 1997;349:462-466.
16. Oltrona L, Ardissino D, Merlini PA, Spinola A, Chiodo F, Pezzano A. C-reactive protein elevation and early outcome in patients with unstable angina pectoris. Am J Cardiol. 1997;80:1002-1006.
17. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease: FRISC Study Group: fragmin during instability in coronary artery disease. Circulation. 1997;96:4204-4210.
18. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Angsburg Cohort Study, 1984 to 1992. Circulation. 1999;99:237-242.
19. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT group. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996; 144:537-547.
20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
21. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
22. Centers for Disease Control and Prevention. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Bethesda, Md: National Center for Health Statistics; 1994. Vital Health Statistics 1(32). Series 1, No. 32.
23. The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) Reference Manuals and Reports [book on CD-ROM]. Bethesda, Md: National Center for Health Statistics; 1996.
24. Centers for Disease Control and Prevention. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Bethesda, Md: National Center for Health Statistics; 1994. Vital Health Statistics 1(32). Series 1, No. 32.
25. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Version 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
26. O'Mahony PG, Dobson R, Rodgers H, James OFW, Thomson RG. Validation of a population screening questionnaire to assess prevalence of stroke. Stroke. 1995;26:1334-1337.